Loading cancer entity…
Loading cancer entity…
Clinical trials
19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06919809 | Effectiveness and Safety of X A-DERM™ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery | completed | N/A | 16 | McGuire InstituteINDUSTRY | 1 | Apr 24, 2026 | clinicaltrials |
| NCT07349940 | Early Detection of Skin Tumors Using a Telemedicine Tool in Primary Care(MEL) | recruiting | N/A | 1,440 | Institute of Health Information and Statistics of the Czech RepublicOTHER_GOV | 1 | Mar 27, 2026 |
| clinicaltrials |
| NCT02723721 | Prospective Study of Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face(PICAMEL) | completed | Phase 2 | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT06014619 | Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs | active not recruiting | — | 500 | Maastricht University Medical CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT03233828 | Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2(IL-2) | terminated | Phase 3 | 1 | Carman GiacomantonioOTHER | 1 | Jul 24, 2024 | clinicaltrials |
| NCT06046144 | Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors(Micro3) | completed | — | 161 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT02394132 | Radiotherapy or Imiquimod in Complex Lentigo Maligna(RADICAL) | completed | Phase 3 | 126 | Melanoma and Skin Cancer Trials LimitedOTHER | 3 | Jun 20, 2024 | clinicaltrials |
| NCT05446155 | BioMEL- Diagnostic and Prognostic Factors in Melanoma.(BioMEL) | recruiting | — | 2,000 | Region SkaneOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT04688749 | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage(DermaSense) | terminated | — | 50 | Aristotle University Of ThessalonikiOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05402059 | Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice(ISABELLA) | unknown | — | 1,570 | MelanomaPRO, RussiaOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT05402046 | Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms(CAMELLIA) | unknown | N/A | 605 | MelanomaPRO, RussiaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT03508297 | Reflectance Confocal Microscopy to Diagnose MM & LM | completed | — | 597 | Skin Care Network Ltd.INDUSTRY | 1 | Nov 12, 2021 | clinicaltrials |
| NCT04695015 | Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm | unknown | — | 100 | Peking UniversityOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT01088737 | Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna | unknown | Phase 2 / Phase 3 | 60 | Medical University of GrazOTHER | 1 | Aug 13, 2019 | clinicaltrials |
| NCT02306512 | Mohs and Immunofluorescence for Malignant Melanoma In Situ | withdrawn | N/A | 0 | University of MiamiOTHER | 1 | Jan 7, 2019 | clinicaltrials |
| NCT02685592 | Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream(LM PDT) | completed | Phase 4 | 10 | Joint Authority for Päijät-Häme Social and Health CareOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT00707174 | Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna | completed | N/A | 90 | University of UtahOTHER | 1 | Jul 31, 2013 | clinicaltrials |
| NCT00785369 | In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis | completed | N/A | 441 | Lucid, Inc.INDUSTRY | 1 | Oct 3, 2012 | clinicaltrials |
| NCT01161888 | Effect of Topical Imiquimod on Lentigo Maligna(LIMIT-1) | completed | Phase 4 | 30 | Jerry MarsdenOTHER | 1 | Jun 20, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Apr 24, 2026source: clinicaltrials